skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Predictors of obstructive sleep apnea in males with metabolic syndrome

Original Research

(2441) Views  (677) Full article downloads

Authors: Nikolaos Papanas, Paschalis Steiropoulos, Evangelia Nena, et al

Published Date April 2010 Volume 2010:6 Pages 281 - 286
DOI: http://dx.doi.org/10.2147/VHRM.S7948

Nikolaos Papanas1, Paschalis Steiropoulos2, Evangelia Nena2, Argyris Tzouvelekis2, Athanasios Skarlatos2, Maria Konsta2, Vasileios Vasdekis3, Efstratios Maltezos1, Demosthenes Bouros2

1Outpatient Clinic of Obesity, Diabetes and Metabolism, Second Department of Internal Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece; 2Sleep Laboratory, Department of Pneumonology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece; 3Department of Statistics, Athens University of Economic and Business, Athens, Greece

Abstract: The aim of the present study was to examine the prevalence of metabolic syndrome (MS) and its components among obstructive sleep apnea (OSA) patients vs controls, as well as to investigate which of these components are strongly associated with the presence of OSA in subjects reporting symptoms indicating sleep-disordered breathing. Included were 83 consecutive male subjects, without known concomitant diseases, who visited an outpatient clinic of obesity, diabetes and metabolism. Based on polysomnography, these were divided into two groups: OSA patients (n = 53) and controls (n = 30). Parameters indicating MS, according to the NCEP ATP III criteria (blood pressure, waist circumference, glucose, triglycerides, and HDL-cholesterol levels) were evaluated in both groups. The criteria for MS were fulfilled in 49 participants. Presence of MS was significantly correlated with the presence of OSA. However, after adjustment for BMI, only serum glucose was significantly associated with the presence of OSA (P = 0.002). Conversely, the presence of MS was associated with a significant reduction in percentage of slow-wave sleep (P = 0.030). In conclusion, these results provide further evidence for the association between OSA and MS. Between subjects with MS, elevated serum glucose levels indicate a higher probability for the presence of OSA.

Keywords: diabetes mellitus, glucose, metabolic syndrome, obstructive sleep apnea








Readers of this article also read:

Safety and efficacy of rosiglitazone in the elderly diabetic patient
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Does plasmin have anticoagulant activity?
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
MRI sagittal abdominal diameter is a stronger predictor of metabolic syndrome than visceral fat area or waist circumference in a high-risk vascular cohort
Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety
Erratum
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University